InsidersTradesSigma
Track the CARDINAL HEALTH INC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, CARDINAL HEALTH INC has recorded 165 public disclosures. Market capitalisation: €54.5bn. The latest transaction was filed on 19 August 2025 (Cession). Among the most active insiders: Mayer Jessica L. The full history is free.
165
Insider Decl.
n/a
Thresholds
€28,928
3 ops.
Buy Volume
€11m
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CARDINAL HEALTH INC Strong Buy (bullish), based on 15 analysts. Average price target: US$248.27.
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,989 of 29,064 companies
34.0
score / 100
Value44
Quality24
FCF yld3.4%
Earn yld2.9%
EV/EBITDA20.1x
ROE·
Gross mgn3.7%
Net mgn0.7%
Debt/EBITDA2.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2025
Declarations165 total
34,455 shares@ US$148.6139.7% of flowCommon SharesSEC:0000721371-25-000093:2
34,866 shares@ US$150.2240.6% of flowCommon SharesSEC:0000721371-25-000093:1
13,788 shares@ US$149.1916.0% of flowCommon SharesSEC:0000721371-25-000093:3
11,363 shares0Common SharesSEC:0000721371-25-000093:0
67,448 shares0Common SharesSEC:0000721371-25-000080:0
5,176 shares@ US$167.189.6% of flowCommon SharesSEC:0000721371-25-000065:0
5,694 shares@ US$167.1815.1% of flowCommon SharesSEC:0000721371-25-000064:0
5,821 shares@ US$167.1813.7% of flowCommon SharesSEC:0000721371-25-000063:0
3,623 shares@ US$167.189.9% of flowCommon SharesSEC:0000721371-25-000062:0
1,049 shares0Common SharesSEC:0000721371-25-000030:0
1,049 shares0Common SharesSEC:0000721371-25-000029:0
1,919 shares@ US$126.212.1% of flowCommon SharesSEC:0000721371-25-000017:0
636 shares@ US$126.2113.1% of flowCommon SharesSEC:0000721371-25-000015:0
90 shares@ US$122.240.9% of flowCommon SharesSEC:0000721371-24-000164:0
632 shares@ US$122.242.1% of flowCommon SharesSEC:0000721371-24-000166:0
676 shares@ US$122.241.1% of flowCommon SharesSEC:0000721371-24-000165:0
355 shares@ US$122.240.8% of flowCommon SharesSEC:0000721371-24-000163:0
5,186 shares@ US$121.298.6% of flowCommon SharesSEC:0000721371-24-000156:0
3,504 shares@ US$123.5537.3% of flowCommon SharesSEC:0000721371-24-000154:0
2,812 shares0Common SharesSEC:0000721371-24-000146:0
1,730 shares0Common SharesSEC:0000721371-24-000152:0
1,730 shares0Common SharesSEC:0000721371-24-000149:0
1,730 shares0Common SharesSEC:0000721371-24-000148:0
1,730 shares0Common SharesSEC:0000721371-24-000144:0
1,730 shares0Common SharesSEC:0000721371-24-000145:0
25 of 165 declarations
关于 CARDINAL HEALTH INC
Cardinal Health Inc. 是一家主要的美国医疗保健服务和产品公司，在纽约证券交易所上市，股票代码为 CAH，总部位于美国俄亥俄州都柏林。该公司成立于 1971 年，已发展成为美国医疗保健供应链中最重要的参与者之一，在药品分销领域拥有悠久的特许经营权，并拥有一个更广泛的平台，服务于医院、药房、医生诊所、实验室、门诊手术中心和居家患者。 Cardinal Health 报告了两个主要的运营部门。药品和专业解决方案是其最大、战略上最重要的业务，专注于品牌药、仿制药和专科药的分销，以及为制造商和医疗保健提供商提供的支持服务。全球医疗产品和分销 (GMPD) 涵盖医疗产品、医院用品和分销解决方案。此外，该公司将几个以增长为导向的业务归类为“其他”，包括核医学和精准健康解决方案、居家解决方案和 OptiFreight Logistics。这种产品组合显示出一种有意的尝试，旨在通过更高增长、更高价值的医疗保健服务来补充低利润但大规模的分销核心业务。 从竞争角度来看，Cardinal Health 是美国主要的药品分销商之一，在一个以规模、物流强度和微薄利润为特征的行业中运营。其竞争优势包括全国范围、采购和履行能力、深厚的客户关系以及在整个医疗保健价值链中提供集成解决方案的能力。该公司还受益于专科药房、患者支持、送货上门、核药房运营以及数据/绩效解决方案，这些都可以支持长期的盈利多元化。 最近的发展具有重要的战略意义。2025 年，Cardinal Health 宣布并完成了对领先的泌尿科 MSO Solaris Health 的收购，加强了 The Specialty Alliance 并扩大了其多专科管理服务平台。它还完成了对 Advanced Diabetes Supply Group 的收购，巩固了其居家解决方案特许经营权。最近，管理层上调了 2026 财年展望，并强调了所有五个运营部门的持续增长势头，以及对自动化、分销能力和网络优化的持续投资。对于国际投资者而言，CAH 仍然是一个成熟但积极转型的美国医疗保健公司，在防御性分销敞口和专科及居家护理领域的选择性增长潜力之间取得了平衡。
